Clinical Trials Browser

Phase 2 × INDUSTRY × 1-methyltryptophan × Clear all

NCT03301636 2022-09-27

NLG2107

Phase 2 Terminated

21 enrolled 11 charts

Melanoma

NCT01792050 2020-05-28

Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms